Log in

Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers

  • Laryngology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Objective

The main objective is to compare the oncologic outcomes of patients with T3 laryngeal cancers who underwent total laryngectomy or organ preservation protocol (OPP) as the initial plan of management.

Materials and methods

This is a retrospective study on 120 patients treated for T3 laryngeal and hypopharyngeal cancers. Patients with functional larynx underwent OPP and dysfunctional larynx underwent upfront laryngectomy. Median follow-up of the patients was 4.6 years.

Results

There was a significant difference in 3 year disease-free survival (DFS) between upfront laryngectomy and OPP (73.2 vs. 55.7%; P = 0.028) group but not in 3 year overall survival (73.2 vs. 68.7%, P = 0.8). The rate laryngeal preservation was 65% in CCRT and 44% in only radiotherapy group. At 3 years, the laryngectomy-free survival was 57.2% and the laryngo-esophageal dysfunction-free survival (LEDS) was 53.0%.

Conclusion

T3 laryngeal cancers treated with upfront laryngectomy have an improved DFS when compared to those treated with non-surgical modalities. Primary surgery should be offered as an option for selected patients especially when CCRT is not feasible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Group* TD of VALCS (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690

    Article  Google Scholar 

  2. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  PubMed  CAS  Google Scholar 

  3. Rieger JM, Zalmanowitz JG, Wolfaardt JF (2006) Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 35:581–587

    Article  PubMed  CAS  Google Scholar 

  4. Staton J, Robbins KT, Newman L, Samant S, Sebelik M, Vieira F (2002) Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 127:43–47

    Article  Google Scholar 

  5. Dias FL, Lima RA, Kligerman J, Cernea CR (2005) Therapeutic options in advanced laryngeal cancer: an overview. ORL 67:311–318

    Article  PubMed  Google Scholar 

  6. Lefebvre J-L, Ang KK (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiat Oncol 73:1293–1303

    Article  Google Scholar 

  7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  8. Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20:921–927

    Article  PubMed  CAS  Google Scholar 

  9. Lefebvre J-L, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol 23:2708–2714

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899

    Article  PubMed  CAS  Google Scholar 

  11. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852. https://doi.org/10.1200/JCO.2012.43.6097

    Article  PubMed  CAS  Google Scholar 

  12. Gorphe P, Matias M, Even C, Ferte C, Bidault F, Garcia G et al (2016) Laryngo-esophageal dysfunction-free survival in a preservation protocol for T3 laryngeal squamous-cell carcinoma. Anticancer Res 36(12):6625–6630

    Article  PubMed  Google Scholar 

  13. Taguchi T, Nishimura G, Takahashi M, Komatsu M, Sano D, Sakuma N et al (2013) Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy. Cancer Chemother Pharmacol 72:837–843

    Article  PubMed  CAS  Google Scholar 

  14. Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1270–1276

    Article  PubMed  Google Scholar 

  15. Hoffman HT, Porter K, Karnell LH et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1–13

    Article  PubMed  Google Scholar 

  16. Al-Gilani M, Skillington SA, Kallogjeri D, Haughey B, Piccirillo JF (2016) Surgical vs nonsurgical treatment modalities for T3 glottic squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 142(10):940–946

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dziegielewski PT, O’Connell DA, Klein M, Fung C, Singh P, Alex Mlynarek M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg J Otorhinolaryngol Chir Cervicofac 41(Suppl 1):S56–S64

    Google Scholar 

  18. Harris BN, Biron VL, Donald P, Farwell DG, Luu QC, Bewley AF et al (2015) Primary surgery vs chemoradiation treatment of advanced-stage hypopharyngeal squamous cell carcinoma. JAMA Otolaryngol Neck Surg 141:636–640

    Article  Google Scholar 

  19. Timmermans AJ, de Gooijer CJ, Hamming–Vrieze O, Hilgers FJ, van den Brekel MW (2015) T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol. Head Neck 37:1495–1503. https://doi.org/10.1002/hed.23789

    Article  PubMed  Google Scholar 

  20. Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589. https://doi.org/10.1200/JCO.2007.14.8841

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sudhir Vasudevan Nair.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nair, S.V., Mair, M., Sawarkar, N. et al. Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers. Eur Arch Otorhinolaryngol 275, 2311–2316 (2018). https://doi.org/10.1007/s00405-018-5047-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-018-5047-8

Keywords

Navigation